Feed Preview
Glioblastoma Multiforme
Glioblastoma Multiforme (GBM) is a tumor that develops from astrocytes and oligodendrocytes. Here is the latest research on mechanisms that underlie GBM and associated therapeutic approaches.
Top 20 most recent papers
Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy
Science AdvancesNovember 1, 2019
Catherine T FloresDuane Anthony Mitchell
4
1
MicroRNA miR-100 decreases glioblastoma growth by targeting SMARCA5 and ErbB3 in tumor-initiating cells
bioRxivDecember 4, 2019
Bahauddeen M AlrfaeiJohn S. Kuo
1
Investigating the Role of Hypoxia-Induced Migration in Glioblastoma Growth Rates
bioRxivDecember 5, 2019
Lee CurtinMarkus R. Owen
4
Gain-Of-Function E76K-Mutant SHP2 Promotes Cell Proliferation, Metastasis, And Tumor Growth In Glioblastoma Through Activation Of The ERK/CREB Pathway
OncoTargets and TherapyNovember 7, 2019
Fan YangSi-Ying Wang
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target
Experimental & Molecular MedicineDecember 6, 2019
Suji HanDo-Hyun Nam
Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
Journal of NeurosurgeryDecember 6, 2019
Víctor Andrés ArrietaAdam M Sonabend
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
CancersDecember 2, 2019
Sanne VennekerJudith V M G Bovée
GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis
Genomics, Proteomics & BioinformaticsDecember 4, 2019
Ya-dong YangXiang-Dong Fang
Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth
Anticancer ResearchDecember 1, 2019
Mana InadaSei-ichi Tanuma
Impact of [64 Cu][Cu(ATSM)] PET/CT in the evaluation of hypoxia in a patient with Glioblastoma: a case report
BMC CancerDecember 6, 2019
Vincenzo GangemiUmberto Sabatini
Reactive oxygen species metabolism-based prediction model and drug for patients with recurrent glioblastoma
AgingDecember 4, 2019
Nian TanWei Min Zhao
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value
AJNR. American Journal of NeuroradiologyDecember 5, 2019
In-Pyeong HwangChul-Ho Sohn
Difference-frequency ultrasound imaging with non-linear contrast
IEEE Transactions on Medical ImagingDecember 3, 2019
Yi-lei LiSteven Chu
1
Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma
JAMA Network OpenDecember 2, 2019
Makoto OhnoTakahiro Ochiya
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
Clinical EpigeneticsDecember 5, 2019
Shirin KarimiGelareh Zadeh
5
Tryptophan 2,3-dioxygenase expression identified in human hepatocellular carcinoma cells and in intratumoral pericytes of most cancers
Cancer Immunology ResearchDecember 5, 2019
Delia HoffmannBenoît J Van den Eynde
1
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma
Anticancer ResearchDecember 1, 2019
Hye Rim HanChung Heon Ryu
Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair
Anticancer ResearchDecember 1, 2019
Go Woon KimSo Hee Kwon
"Keeping a Cool Head": Percutaneous Imaging-Guided Cryo-ablation as Salvage Therapy for Recurrent Glioblastoma and Head and Neck Tumours
Cardiovascular and Interventional RadiologyDecember 3, 2019
Afshin GangiFrançois Proust
A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study)
Japanese Journal of Clinical OncologyDecember 5, 2019
Tomohiro KadotaRyo Nishikawa